Cargando…
Reversible Choreoathetosis in a Patient with End-stage Renal Disease from Administration of Ceftriaxone
A wide spectrum of neurological manifestations may be induced in patients with impaired renal function when receiving beta-lactam antibiotics due to the altered pharmacokinetics. Beta-lactam antibiotics is commonly chosen for treatment in patients with end-stage renal disease due to its good penetra...
Autores principales: | Tan, Mei Ling, Tun, War War Win |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825443/ https://www.ncbi.nlm.nih.gov/pubmed/31723523 http://dx.doi.org/10.7759/cureus.5764 |
Ejemplares similares
-
Outcomes of end‐stage renal disease patients in the PROCESS trial
por: Huebinger, Ryan M., et al.
Publicado: (2021) -
Ceftriaxone-Induced Immune Hemolytic Anemia
por: Singh, Anil, et al.
Publicado: (2020) -
The Impact of COVID-19 Infection Control Measures on End-Stage Renal Disease Patients in a Community Hemodialysis Setting
por: Khan, Behram A, et al.
Publicado: (2023) -
End-Stage Renal Disease Patients on Chronic Hemodialysis Fare Better With COVID-19: A Retrospective Cohort Study From the New York Metropolitan Region
por: Naaraayan, Ashutossh, et al.
Publicado: (2020) -
An In Vitro Susceptibility Study of Cefotaxime-Sulbactam on Clinical Bacterial Isolates From Various Regions in India: A Comparison With Ceftriaxone-Sulbactam
por: Gondane, Ajitkumar A, et al.
Publicado: (2023)